SBC — SBC Medical group Income Statement
0.000.00%
- $459.00m
- $335.47m
- $205.42m
- 94
- 72
- 35
- 76
Annual income statement for SBC Medical group, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 174 | 194 | 205 |
Cost of Revenue | |||
Gross Profit | 115 | 137 | 156 |
Selling / General / Administrative Expenses | |||
Unusual Expense / Income | |||
Total Operating Expenses | 154 | 123 | 131 |
Operating Profit | 20.1 | 70.7 | 74.1 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 23.7 | 73.6 | 73.5 |
Provision for Income Taxes | |||
Net Income After Taxes | 5.55 | 38.6 | 46.7 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 6.32 | 39.4 | 46.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 6.32 | 39.4 | 46.6 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.047 | 0.34 | 0.551 |
Dividends per Share |